In the Columbia-GN cohort, we identified 39 (3.6%) individuals with a monogenic glomerular disorder, mainly in patients with FSGS (35 individuals), along with 66 individuals (6.0%) with high-risk APOL1 genotypes. Here, APOL1 is linked to focal segmental glomerulosclerosis.